What laboratory finding would predominantly indicate the efficacy of warfarin therapy?

What laboratory finding would predominantly indicate the efficacy of warfarin therapy?

• A. Increased platelet count
• B. Prolonged prothrombin time
• C. Prolonged aPTT
• D. Increased thrombin time

Answer: (B)

The efficacy of warfarin therapy is primarily monitored through the prothrombin time (PT), and more specifically, the International Normalized Ratio (INR), which standardizes PT results. Warfarin is an anticoagulant that works by inhibiting vitamin K-dependent clotting factors, which include factors II (prothrombin), VII, IX, and X. As warfarin is administered, the production of these factors is decreased, resulting in a prolonged PT. A prolonged prothrombin time indicates that the blood is taking longer to clot, which reflects the anticoagulant effect of warfarin. Monitoring PT or INR allows healthcare providers to adjust the dosage of warfarin to maintain therapeutic anticoagulation, thereby reducing the risk of thromboembolic events, such as stroke or deep vein thrombosis. While other lab tests mentioned could provide information regarding coagulation, they are not primarily used for monitoring warfarin's effectiveness. Increased platelet count is not directly related to warfarin activity, and the activated partial thromboplastin time (aPTT) is typically more relevant for monitoring heparin therapy. Increased thrombin time may indicate abnormalities in the clotting cascade or the presence of direct thrombin inhibitors

The efficacy of warfarin therapy is primarily monitored through the prothrombin time (PT), and more specifically, the International Normalized Ratio (INR), which standardizes PT results. Warfarin is an anticoagulant that works by inhibiting vitamin K-dependent clotting factors, which include factors II (prothrombin), VII, IX, and X. As warfarin is administered, the production of these factors is decreased, resulting in a prolonged PT.

A prolonged prothrombin time indicates that the blood is taking longer to clot, which reflects the anticoagulant effect of warfarin. Monitoring PT or INR allows healthcare providers to adjust the dosage of warfarin to maintain therapeutic anticoagulation, thereby reducing the risk of thromboembolic events, such as stroke or deep vein thrombosis.

While other lab tests mentioned could provide information regarding coagulation, they are not primarily used for monitoring warfarin's effectiveness. Increased platelet count is not directly related to warfarin activity, and the activated partial thromboplastin time (aPTT) is typically more relevant for monitoring heparin therapy. Increased thrombin time may indicate abnormalities in the clotting cascade or the presence of direct thrombin inhibitors